Oral Iopamidol in Multidetector Computed Tomography-Module 2

Oral Iopamidol in Multidetector Computed Tomography-Module 2

On-Demand Webcast
Presenter

Greg Zobel, BS, RT(R) (CT)
Team Leader, CT
St Francis Hospitals and Health Services
Adjunct Lecturer, Indiana School of Medicine
Indianapolis, Indiana

 

Target Audience

This activity is designed for radiologists, radiology nurses, and radiology technologists.

Learning Objectives

After completing this activity, participants should be able to:

  • Apply the experiences of single center experiences within your own practice about the effectiveness of oral iopamidol in multidetector computed tomography (MDCT)
  • Discuss the patient selection criteria for use of Oral Iopamidol in MDCT
  • Describe the benefits and limitations of oral iopamidol vs intravenous contrast in patients undergoing MDCT
Activity Overview

This on-demand audio webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Date of last review: February 23, 2016

Release Date: December 21, 2009

Expiration Date: February 28, 2020

Estimated time to complete: 30 minutes

For questions regarding this activity, please contact 609-371-1137

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

   In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME Accreditation

NACCME designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Accreditation

This continuing nursing education activity awards .50 contact hour.

AHRA Accreditation

Oral Iopamidol in Multidetector Computed Tomography-Module 2 has been approved for 1 ARRT Category A CE credit by The Association for Medical Imaging Management, AHRA. 

AHRA is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

 


Planning Committee

The planning committee comprises Farnoosh Sokhandon, MD; Greg Zobel, BS, RT; Robert Dieter, MD, RVT, FACC; Michael Wholey, MD, MBA; Susie Seaman, NP; and MaryEllen Fama, Emily Gibson, Jennifer Ilcyn, Randy Robbin, and Susan Yarbrough, NACCME.

Independent Clinical Reviewers:

Michael Wholey, MD, MBA
Dept of Cardiovascular and Interventional Radiology
University of Texas Health Science Center at San Antonio, San Antonio, Texas

Robert S. Dieter, MD, RVT, FACC
Loyola University Medicine, Chicago, IL 

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Ms. Seaman: Advisory Board—Mölnlycke

Dr. Sokhandon, Dr. Zobel, Dr. Dieter, Dr. Wholey, Ms. Fama, Ms. Gibson, Ms. Ilcyn, Mr. Robbin, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of oral iopamidol in multidetector computed tomography.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Bracco Diagnostics, Inc